◉ Type 2 Diabetes

International Diabetes Federation estimates that 537 million people live with diabetes. This disease costs 5 million lives and a medical expense of 70 billion USD annually.

Type 2 Diabetes (T2D) is characterized by insulin deficiency and insulin resistance, leading to hyperglycemia and related complications including, cardiovascular diseases, retinopathy, neuropathy, nephropathy, foot ulcers, etc. Genetic and environmental factors contribute to diabetes.

Currently, tens of anti-diabetic drugs, which target insulin resistance, insulin secretion and glucose homeostasis, fail to cure T2D. Therefore, seeking new approaches to cure T2D is highly demanded.

PS-001 can prevent beta cell failure and reverse type 2 diabetes:

https://www.embopress.org/doi/full/10.15252/emmm.201911668